Literature DB >> 30486555

[Chinese guidelines for diagnosis and treatment of HIV/AIDS (2018)].

.   

Abstract

(AIDS) is an important public health problem in China. In 2005, the first edition of the guidelines for the diagnosis and treatment of AIDS was formulated by the AIDS Professional Group of Society of Infectious Diseases of Chinese Medical Association, which was updated twice in 2011 and 2015. The fourth edition of the guidelines in 2018 is revised on the basis of national clinical practice and the latest research studies. The new research progress in opportunistic infections and human immunodeficency virus(HIV) associated cancers, antiretroviral therapy, HIV post-exposure prophylaxis, and prevention of mother to child transmission were updated in these guidelines. In the 2018 edition, pre-exposure prophylaxis is mentioned for the first time. The strategy of whole course management of HIV infection is put forward in the current version, which needs the participation of multidisciplinary team in prophylaxis, early diagnosis, individualized treatment and humanistic care.

Entities:  

Keywords:  Acquired immunodeficiency syndrome; Diagnosis; Treatment

Mesh:

Year:  2018        PMID: 30486555     DOI: 10.3760/cma.j.issn.0578-1426.2018.12.002

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  45 in total

1.  Risk Behavior Not Associated with Self-Perception of PrEP Candidacy: Implications for Designing PrEP Services.

Authors:  Lu Xie; Yumeng Wu; Siyan Meng; Jianhua Hou; Rong Fu; Huang Zheng; Na He; Min Wang; Kathrine Meyers
Journal:  AIDS Behav       Date:  2019-10

2.  The Development of a Personalized Symptom Management Mobile Health Application for Persons Living with HIV in China.

Authors:  Shuyu Han; Yaolin Pei; Lina Wang; Yan Hu; Xiang Qi; Rui Zhao; Lin Zhang; Wenxiu Sun; Zheng Zhu; Bei Wu
Journal:  J Pers Med       Date:  2021-04-25

3.  Measuring and explaining inequality of continuous care for people living with HIV receiving antiretroviral therapy in Kunming, China.

Authors:  Yongmei Jin; Sawitri Assanangkornchai; Yingrong Du; Jun Liu; Jingsong Bai; Yongrui Yang
Journal:  PLoS One       Date:  2021-05-11       Impact factor: 3.240

4.  Very high baseline HIV viremia impairs efficacy of non-nucleoside reverse transcriptase inhibitor-based ART: a long-term observation in treatment-naïve patients.

Authors:  Shuai Chen; Yang Han; Xiao-Jing Song; Yan-Ling Li; Ting Zhu; Hong-Zhou Lu; Xiao-Ping Tang; Tong Zhang; Min Zhao; Yun He; Sheng-Hua He; Min Wang; Yong-Zhen Li; Shao-Biao Huang; Yong Li; Jing Liu; Wei Cao; Tai-Sheng Li
Journal:  Infect Dis Poverty       Date:  2020-06-22       Impact factor: 4.520

5.  Timing of antiretroviral therapy for HIV-infected patients with moderate to severe Pneumocystis pneumonia: study protocol for a multi-centre prospective randomised controlled trial.

Authors:  Yuanyuan Qin; Yanqiu Lu; Yihong Zhou; Vijay Harypursat; Feng Sun; Sen Yang; Shengquan Tang; Yao Li; Xiaoqing He; Yanming Zeng; Yaokai Chen
Journal:  Trials       Date:  2020-06-22       Impact factor: 2.279

Review 6.  [Pharmaceutical care for severe and critically ill patients with COVID-19].

Authors:  Saiping Jiang; Lu Li; Renping Ru; Chunhong Zhang; Yuefeng Rao; Bin Lin; Rongrong Wang; Na Chen; Xiaojuan Wang; Hongliu Cai; Jifang Sheng; Jianying Zhou; Xiaoyang Lu; Yunqing Qiu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

7.  Human umbilical cord mesenchymal stem cell transfusion in immune non-responders with AIDS: a multicenter randomized controlled trial.

Authors:  Lifeng Wang; Zheng Zhang; Ruonan Xu; Xicheng Wang; Zhanjun Shu; Xiejie Chen; Siyu Wang; Jiaye Liu; Yuanyuan Li; Li Wang; Mi Zhang; Wei Yang; Ying Wang; Huihuang Huang; Bo Tu; Zhiwei Liang; Linghua Li; Jingxin Li; Yuying Hou; Ming Shi; Fu-Sheng Wang
Journal:  Signal Transduct Target Ther       Date:  2021-06-09

8.  [Clinical analysis in five patients with acute leukemia and HIV infection].

Authors:  L Wang; Y Zhang; W Wang; L Zhang; C Yang; J L Zhuang; B Han; D B Zhou; M Chen
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-06-14

9.  The Challenge of Potential Drug-Drug Interactions Among People Living With HIV on Antiretroviral Therapy: A Cross-Sectional Study in Selected Provinces in China.

Authors:  Huan Xia; Liying Gao; Xiaowen Gong; Silvere D Zaongo; Tong Zhang; Hao Wu; Ping Ma; Xiaojie Huang
Journal:  Front Pharmacol       Date:  2020-05-27       Impact factor: 5.810

10.  A Prognostic Model to Assess Long-Term Survival of Patients on Antiretroviral Therapy: A 15-Year Retrospective Cohort Study in Southwestern China.

Authors:  He Jiang; Qiuying Zhu; Yi Feng; Jinghua Huang; Zongxiang Yuan; Xinjuan Zhou; Guanghua Lan; Hao Liang; Yiming Shao
Journal:  Open Forum Infect Dis       Date:  2021-06-12       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.